Conditions: Alcoholism
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 156
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the effects of quetiapine in reducing percent heavy drinking days and increasing percent abstinent days in alcohol dependent patients who are frequent heavy drinkers.

Detailed description:
This trial is a phase 2, randomized, double-blind, placebo-controlled, parallel group trial intended to assess the efficacy of quetiapine compared to placebo in alcoholics who are frequent heavy drinkers.

Arms:
arm 1: Seroquel arm 2: Placebo

Interventions: intervention 1: Seroquel intervention 2: Placebo
Intervention descriptions: intervention 1: 400 mg/day intervention 2: 400 mg/day

Protocol document: